Anti-ableist oncology care: ensuring equity for people with physical disabilities

Ableism, broadly defined, is discrimination towards people with disabilities, including use of language that excludes the unique needs and skills of people with disabilities, normalises people with typical abilities, and suggests that those with disabilities require so-called fixing.1 Ableism in hea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet oncology 2023-11, Vol.24 (11), p.1168-1170
Hauptverfasser: Smith, Sean R, Blauwet, Cheri, Wells, Thomas Peter Edward
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1170
container_issue 11
container_start_page 1168
container_title The lancet oncology
container_volume 24
creator Smith, Sean R
Blauwet, Cheri
Wells, Thomas Peter Edward
description Ableism, broadly defined, is discrimination towards people with disabilities, including use of language that excludes the unique needs and skills of people with disabilities, normalises people with typical abilities, and suggests that those with disabilities require so-called fixing.1 Ableism in health care must be recognised and rejected. The respondents also overwhelmingly reported that they felt that quality of life was lower for people with disabilities than for people without disabilities.6 It is also concerning that a 2020 study found that over 80% of health-care professionals in the USA implicitly preferred treating people without disabilities.7 This bias might contribute to lower cancer screening rates for patients with disabilities and unclear treatment decision making.8 People with physical mobility deficits and cancer report a lack of accessible equipment, providers being uninformed about their unique needs, and the sense that their cancer might have been treated differently due to their pre-existing disability.9 Access to care must be easier, and shared decision making simplified, for this vulnerable population who receive less treatment and staging investigations, and have poorer outcomes compared with individuals with no disability. Little has been published on the topic of treatment decision making for people with disabilities, but a study among medical oncologists in Turkey regarding whether hypothetical patients with disabilities were suitable for antineoplastic treatment found discordance, although some suggested that treatment was appropriate.10 Measuring the performance status of a person with a disability can be challenging and requires a holistic look at their life beyond performance status assessments, including adaptations they use in daily life, the need for assistance, and environmental barriers they encounter. Language in performance status measures Karnofsky Performance Status Scale 100 Normal, no complaints, no evidence of disease 90 Able to carry on normal activity, minor signs or symptoms of disease 80 Normal activity with efforts, some signs or symptoms of disease 70 Cares for self, unable to carry on normal activity or do active work 60 Requires occasional assistance, but is able to care for most personal needs 50 Requires considerable assistance and frequent medical care 40* Disabled, requires special care and assistance 30 Severely disabled, hospital admission is indicated although death not imminent 20 Very sick, hospita
doi_str_mv 10.1016/S1470-2045(23)00406-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2886602378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2884672476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-fe069ebd5e1f2ce08c478c81988c81a54c3bad63ed6a084f789444a1593f9a823</originalsourceid><addsrcrecordid>eNpdkE1r3DAQhkVp6SZpfkKDoJfNwe3ow5Kc2xLapLAQQpuzkOVxosVrOZJN2H9f726aQy4zw_C8w_AQ8pXBdwZM_fjDpIaCgyyXXFwCSFAFfCAn81oWpTTm42E-IgtymvMGgGkG5WeyELrivOL6hNyv-jEUru4w5JHG3scuPu6odwmvKPZ5SqF_pPg8hXFH25jogHHokL6E8YkOT7scvOtoE7KrQxfGgPkL-dS6LuP5az8jD79-_r2-LdZ3N7-vV-vCC6HHokVQFdZNiazlHsF4qY03rDL76krpRe0aJbBRDoxstamklI6VlWgrZ7g4I8vj3SHF5wnzaLche-w612OcsuXGKAVcaDOj396hmzilfv5uT0mludRqpsoj5VPMOWFrhxS2Lu0sA7t3bg_O7V6o5cIenFuYcxev16d6i81b6r9k8Q_dhnxo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2884672476</pqid></control><display><type>article</type><title>Anti-ableist oncology care: ensuring equity for people with physical disabilities</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Smith, Sean R ; Blauwet, Cheri ; Wells, Thomas Peter Edward</creator><creatorcontrib>Smith, Sean R ; Blauwet, Cheri ; Wells, Thomas Peter Edward</creatorcontrib><description>Ableism, broadly defined, is discrimination towards people with disabilities, including use of language that excludes the unique needs and skills of people with disabilities, normalises people with typical abilities, and suggests that those with disabilities require so-called fixing.1 Ableism in health care must be recognised and rejected. The respondents also overwhelmingly reported that they felt that quality of life was lower for people with disabilities than for people without disabilities.6 It is also concerning that a 2020 study found that over 80% of health-care professionals in the USA implicitly preferred treating people without disabilities.7 This bias might contribute to lower cancer screening rates for patients with disabilities and unclear treatment decision making.8 People with physical mobility deficits and cancer report a lack of accessible equipment, providers being uninformed about their unique needs, and the sense that their cancer might have been treated differently due to their pre-existing disability.9 Access to care must be easier, and shared decision making simplified, for this vulnerable population who receive less treatment and staging investigations, and have poorer outcomes compared with individuals with no disability. Little has been published on the topic of treatment decision making for people with disabilities, but a study among medical oncologists in Turkey regarding whether hypothetical patients with disabilities were suitable for antineoplastic treatment found discordance, although some suggested that treatment was appropriate.10 Measuring the performance status of a person with a disability can be challenging and requires a holistic look at their life beyond performance status assessments, including adaptations they use in daily life, the need for assistance, and environmental barriers they encounter. Language in performance status measures Karnofsky Performance Status Scale 100 Normal, no complaints, no evidence of disease 90 Able to carry on normal activity, minor signs or symptoms of disease 80 Normal activity with efforts, some signs or symptoms of disease 70 Cares for self, unable to carry on normal activity or do active work 60 Requires occasional assistance, but is able to care for most personal needs 50 Requires considerable assistance and frequent medical care 40* Disabled, requires special care and assistance 30 Severely disabled, hospital admission is indicated although death not imminent 20 Very sick, hospital admission necessary, active support treatment necessary 10 Moribund, fatal process progressing rapidly 0 Dead WHO ECOG Performance Status Scale 0 Fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity, but ambulatory and able to carry out</description><identifier>ISSN: 1470-2045</identifier><identifier>ISSN: 1474-5488</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(23)00406-0</identifier><identifier>PMID: 37922927</identifier><language>eng</language><publisher>England: Elsevier Limited</publisher><subject>Cancer ; Cancer screening ; Decision making ; Disability discrimination ; Disabled Persons ; Discordance ; Handicapped accessibility ; Health care access ; Health Equity ; Humans ; Language ; Medical screening ; Oncology ; Patients ; People with disabilities ; Quality of life ; Wheelchairs</subject><ispartof>The lancet oncology, 2023-11, Vol.24 (11), p.1168-1170</ispartof><rights>2023. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-fe069ebd5e1f2ce08c478c81988c81a54c3bad63ed6a084f789444a1593f9a823</citedby><cites>FETCH-LOGICAL-c337t-fe069ebd5e1f2ce08c478c81988c81a54c3bad63ed6a084f789444a1593f9a823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2884672476?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,782,786,27933,27934,64394,64396,64398,72478</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37922927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Sean R</creatorcontrib><creatorcontrib>Blauwet, Cheri</creatorcontrib><creatorcontrib>Wells, Thomas Peter Edward</creatorcontrib><title>Anti-ableist oncology care: ensuring equity for people with physical disabilities</title><title>The lancet oncology</title><addtitle>Lancet Oncol</addtitle><description>Ableism, broadly defined, is discrimination towards people with disabilities, including use of language that excludes the unique needs and skills of people with disabilities, normalises people with typical abilities, and suggests that those with disabilities require so-called fixing.1 Ableism in health care must be recognised and rejected. The respondents also overwhelmingly reported that they felt that quality of life was lower for people with disabilities than for people without disabilities.6 It is also concerning that a 2020 study found that over 80% of health-care professionals in the USA implicitly preferred treating people without disabilities.7 This bias might contribute to lower cancer screening rates for patients with disabilities and unclear treatment decision making.8 People with physical mobility deficits and cancer report a lack of accessible equipment, providers being uninformed about their unique needs, and the sense that their cancer might have been treated differently due to their pre-existing disability.9 Access to care must be easier, and shared decision making simplified, for this vulnerable population who receive less treatment and staging investigations, and have poorer outcomes compared with individuals with no disability. Little has been published on the topic of treatment decision making for people with disabilities, but a study among medical oncologists in Turkey regarding whether hypothetical patients with disabilities were suitable for antineoplastic treatment found discordance, although some suggested that treatment was appropriate.10 Measuring the performance status of a person with a disability can be challenging and requires a holistic look at their life beyond performance status assessments, including adaptations they use in daily life, the need for assistance, and environmental barriers they encounter. Language in performance status measures Karnofsky Performance Status Scale 100 Normal, no complaints, no evidence of disease 90 Able to carry on normal activity, minor signs or symptoms of disease 80 Normal activity with efforts, some signs or symptoms of disease 70 Cares for self, unable to carry on normal activity or do active work 60 Requires occasional assistance, but is able to care for most personal needs 50 Requires considerable assistance and frequent medical care 40* Disabled, requires special care and assistance 30 Severely disabled, hospital admission is indicated although death not imminent 20 Very sick, hospital admission necessary, active support treatment necessary 10 Moribund, fatal process progressing rapidly 0 Dead WHO ECOG Performance Status Scale 0 Fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity, but ambulatory and able to carry out</description><subject>Cancer</subject><subject>Cancer screening</subject><subject>Decision making</subject><subject>Disability discrimination</subject><subject>Disabled Persons</subject><subject>Discordance</subject><subject>Handicapped accessibility</subject><subject>Health care access</subject><subject>Health Equity</subject><subject>Humans</subject><subject>Language</subject><subject>Medical screening</subject><subject>Oncology</subject><subject>Patients</subject><subject>People with disabilities</subject><subject>Quality of life</subject><subject>Wheelchairs</subject><issn>1470-2045</issn><issn>1474-5488</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkE1r3DAQhkVp6SZpfkKDoJfNwe3ow5Kc2xLapLAQQpuzkOVxosVrOZJN2H9f726aQy4zw_C8w_AQ8pXBdwZM_fjDpIaCgyyXXFwCSFAFfCAn81oWpTTm42E-IgtymvMGgGkG5WeyELrivOL6hNyv-jEUru4w5JHG3scuPu6odwmvKPZ5SqF_pPg8hXFH25jogHHokL6E8YkOT7scvOtoE7KrQxfGgPkL-dS6LuP5az8jD79-_r2-LdZ3N7-vV-vCC6HHokVQFdZNiazlHsF4qY03rDL76krpRe0aJbBRDoxstamklI6VlWgrZ7g4I8vj3SHF5wnzaLche-w612OcsuXGKAVcaDOj396hmzilfv5uT0mludRqpsoj5VPMOWFrhxS2Lu0sA7t3bg_O7V6o5cIenFuYcxev16d6i81b6r9k8Q_dhnxo</recordid><startdate>202311</startdate><enddate>202311</enddate><creator>Smith, Sean R</creator><creator>Blauwet, Cheri</creator><creator>Wells, Thomas Peter Edward</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>202311</creationdate><title>Anti-ableist oncology care: ensuring equity for people with physical disabilities</title><author>Smith, Sean R ; Blauwet, Cheri ; Wells, Thomas Peter Edward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-fe069ebd5e1f2ce08c478c81988c81a54c3bad63ed6a084f789444a1593f9a823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer</topic><topic>Cancer screening</topic><topic>Decision making</topic><topic>Disability discrimination</topic><topic>Disabled Persons</topic><topic>Discordance</topic><topic>Handicapped accessibility</topic><topic>Health care access</topic><topic>Health Equity</topic><topic>Humans</topic><topic>Language</topic><topic>Medical screening</topic><topic>Oncology</topic><topic>Patients</topic><topic>People with disabilities</topic><topic>Quality of life</topic><topic>Wheelchairs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Sean R</creatorcontrib><creatorcontrib>Blauwet, Cheri</creatorcontrib><creatorcontrib>Wells, Thomas Peter Edward</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Sean R</au><au>Blauwet, Cheri</au><au>Wells, Thomas Peter Edward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-ableist oncology care: ensuring equity for people with physical disabilities</atitle><jtitle>The lancet oncology</jtitle><addtitle>Lancet Oncol</addtitle><date>2023-11</date><risdate>2023</risdate><volume>24</volume><issue>11</issue><spage>1168</spage><epage>1170</epage><pages>1168-1170</pages><issn>1470-2045</issn><issn>1474-5488</issn><eissn>1474-5488</eissn><abstract>Ableism, broadly defined, is discrimination towards people with disabilities, including use of language that excludes the unique needs and skills of people with disabilities, normalises people with typical abilities, and suggests that those with disabilities require so-called fixing.1 Ableism in health care must be recognised and rejected. The respondents also overwhelmingly reported that they felt that quality of life was lower for people with disabilities than for people without disabilities.6 It is also concerning that a 2020 study found that over 80% of health-care professionals in the USA implicitly preferred treating people without disabilities.7 This bias might contribute to lower cancer screening rates for patients with disabilities and unclear treatment decision making.8 People with physical mobility deficits and cancer report a lack of accessible equipment, providers being uninformed about their unique needs, and the sense that their cancer might have been treated differently due to their pre-existing disability.9 Access to care must be easier, and shared decision making simplified, for this vulnerable population who receive less treatment and staging investigations, and have poorer outcomes compared with individuals with no disability. Little has been published on the topic of treatment decision making for people with disabilities, but a study among medical oncologists in Turkey regarding whether hypothetical patients with disabilities were suitable for antineoplastic treatment found discordance, although some suggested that treatment was appropriate.10 Measuring the performance status of a person with a disability can be challenging and requires a holistic look at their life beyond performance status assessments, including adaptations they use in daily life, the need for assistance, and environmental barriers they encounter. Language in performance status measures Karnofsky Performance Status Scale 100 Normal, no complaints, no evidence of disease 90 Able to carry on normal activity, minor signs or symptoms of disease 80 Normal activity with efforts, some signs or symptoms of disease 70 Cares for self, unable to carry on normal activity or do active work 60 Requires occasional assistance, but is able to care for most personal needs 50 Requires considerable assistance and frequent medical care 40* Disabled, requires special care and assistance 30 Severely disabled, hospital admission is indicated although death not imminent 20 Very sick, hospital admission necessary, active support treatment necessary 10 Moribund, fatal process progressing rapidly 0 Dead WHO ECOG Performance Status Scale 0 Fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity, but ambulatory and able to carry out</abstract><cop>England</cop><pub>Elsevier Limited</pub><pmid>37922927</pmid><doi>10.1016/S1470-2045(23)00406-0</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1470-2045
ispartof The lancet oncology, 2023-11, Vol.24 (11), p.1168-1170
issn 1470-2045
1474-5488
1474-5488
language eng
recordid cdi_proquest_miscellaneous_2886602378
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Cancer
Cancer screening
Decision making
Disability discrimination
Disabled Persons
Discordance
Handicapped accessibility
Health care access
Health Equity
Humans
Language
Medical screening
Oncology
Patients
People with disabilities
Quality of life
Wheelchairs
title Anti-ableist oncology care: ensuring equity for people with physical disabilities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T02%3A43%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-ableist%20oncology%20care:%20ensuring%20equity%20for%20people%20with%20physical%20disabilities&rft.jtitle=The%20lancet%20oncology&rft.au=Smith,%20Sean%20R&rft.date=2023-11&rft.volume=24&rft.issue=11&rft.spage=1168&rft.epage=1170&rft.pages=1168-1170&rft.issn=1470-2045&rft.eissn=1474-5488&rft_id=info:doi/10.1016/S1470-2045(23)00406-0&rft_dat=%3Cproquest_cross%3E2884672476%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2884672476&rft_id=info:pmid/37922927&rfr_iscdi=true